Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Solventum (SOLV)

Solventum raises 2025 adjusted EPS outlook to $5.80-$5.95 as Q2 sales rise 3.9%

Positive Impact 4 of 5 earnings Written later

Solventum reported second-quarter 2025 net sales up 3.9% to $2.2 billion, with adjusted diluted EPS of $1.69 versus $1.56 a year earlier. The company raised its full-year 2025 adjusted EPS outlook to $5.80-$5.95 and its organic sales growth outlook to 2.0%-3.0%, but GAAP operating income margin and quarterly free cash flow declined.

Key points

  • Q2 net sales rose 3.9% to $2.2 billion; organic sales rose 2.8%.
  • Adjusted diluted EPS was $1.69, up 8.3%; GAAP diluted EPS was $0.51, flat year over year.
  • Full-year adjusted EPS outlook raised to $5.80-$5.95 from $5.45-$5.65; organic sales growth outlook raised to +2.0% to +3.0%.
  • GAAP operating income margin fell to 9.9% from 11.7%; Q2 free cash flow was $59 million versus $297 million.

The filing

CompanySolventum (SOLV)
Form8-K, current report
Filed with the SECAug 7, 2025, 4:12 PM ET
Accession number0001964738-25-000062

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.